TY - JOUR
T1 - Differential selectivity of hyaluronidase inhibitors toward acidic and basic hyaluronidases
AU - Isoyama, Tadahiro
AU - Thwaites, Dwayne
AU - Selzer, Marie G.
AU - Carey, Robert I.
AU - Barbucci, Rolando
AU - Lokeshwar, Vinata B.
N1 - Funding Information:
We thank Dr. Thomas Harris, Department of Biochemistry and Molecular Biology, University of Miami, and Jack J. Skalicky, Department of Biochemistry, University of Utah School of Medicine for helpful discussions during the course of this work. NCI grant RO1 CA 072821-06A2; Department of Defense grant DAMD 170210005; American Cancer Society Florida Division. Dr. T.I. was supported by Tottori University Hospital, Japan.
PY - 2006/1
Y1 - 2006/1
N2 - Hyaluronidase (HAase), a class of enzymes which degrade hyaluronic acid (HA), are involved in the spread of infections/toxins, ovum fertilization, and cancer progression. Thus, HAase inhibitors may have use in disease treatments. We evaluated 21 HAase inhibitors against HYAL-1, testicular, honeybee, and Streptomyces HAases. Among these inhibitors, polymers of poly (styrene-4-sulfonate) (PSS) (i.e., molecular weight 1400-990,000 or PSS 1400-PSS 990,000) and O-sulfated HA (sHA) derivatives (sHA2.0, 2.5, and 2.75) were the most effective. HYAL-1 and bee HAases were the most sensitive, followed by testicular HAase; Streptomyces HAase was resistant to all inhibitors, except PSS 990,000 and VERSA-TL 502 (i.e., PSS 106 dalton). The length of the PSS polymer determined their potency (e.g., IC50 for HYAL-1, PSS 990,000: 0.0096 μM; PSS 210 no inhibition; IC50 for testicular HAase, PSS 990,000: 0.042 μM; PSS 210 no inhibition). The presence, but not the number, of sulfate groups on the sHA molecule determined its potency (e.g., IC50 for HYAL-1: sHA2.0, 0.019 μM; sHA2.75, 0.0083 μM). Other known HAase inhibitors, such as gossypol, sodium-aurothiomalate, 1-tetradecane sulfonic acid, and glycerrhizic acid, were not effective. Both PSS and sHA inhibited HAases by a mixed inhibition mechanism (i.e., competitive + uncompetitive) and were 5- to 17-fold better as uncompetitive inhibitors than as competitive inhibitors. These results demonstrate that HAase inhibitors show selectivity toward the different types of HAases, which could be exploited to inhibit specific HAases involved in a variety of pathophysiologic conditions.
AB - Hyaluronidase (HAase), a class of enzymes which degrade hyaluronic acid (HA), are involved in the spread of infections/toxins, ovum fertilization, and cancer progression. Thus, HAase inhibitors may have use in disease treatments. We evaluated 21 HAase inhibitors against HYAL-1, testicular, honeybee, and Streptomyces HAases. Among these inhibitors, polymers of poly (styrene-4-sulfonate) (PSS) (i.e., molecular weight 1400-990,000 or PSS 1400-PSS 990,000) and O-sulfated HA (sHA) derivatives (sHA2.0, 2.5, and 2.75) were the most effective. HYAL-1 and bee HAases were the most sensitive, followed by testicular HAase; Streptomyces HAase was resistant to all inhibitors, except PSS 990,000 and VERSA-TL 502 (i.e., PSS 106 dalton). The length of the PSS polymer determined their potency (e.g., IC50 for HYAL-1, PSS 990,000: 0.0096 μM; PSS 210 no inhibition; IC50 for testicular HAase, PSS 990,000: 0.042 μM; PSS 210 no inhibition). The presence, but not the number, of sulfate groups on the sHA molecule determined its potency (e.g., IC50 for HYAL-1: sHA2.0, 0.019 μM; sHA2.75, 0.0083 μM). Other known HAase inhibitors, such as gossypol, sodium-aurothiomalate, 1-tetradecane sulfonic acid, and glycerrhizic acid, were not effective. Both PSS and sHA inhibited HAases by a mixed inhibition mechanism (i.e., competitive + uncompetitive) and were 5- to 17-fold better as uncompetitive inhibitors than as competitive inhibitors. These results demonstrate that HAase inhibitors show selectivity toward the different types of HAases, which could be exploited to inhibit specific HAases involved in a variety of pathophysiologic conditions.
KW - HYAL1
KW - Hyaluronic acid
KW - Hyaluronidase
KW - Hyaluronidase inhibitors
UR - http://www.scopus.com/inward/record.url?scp=29444443660&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=29444443660&partnerID=8YFLogxK
U2 - 10.1093/glycob/cwj036
DO - 10.1093/glycob/cwj036
M3 - Article
C2 - 16166602
AN - SCOPUS:29444443660
SN - 0959-6658
VL - 16
SP - 11
EP - 21
JO - Glycobiology
JF - Glycobiology
IS - 1
ER -